Buscar
Mostrando ítems 1-10 de 721
Insulin resistance and polycystic ovary syndrome through life
(2012)
The heterogeneity of Polycystic Ovary Syndrome (PCOS) emphasizes the need for a consensual review of the data concerning its diagnosis and treatment and for determination of the relationship between the development of PCOS ...
The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy
(Hindawi Publishing Corporation, 2018-06)
Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin ...
The polycystic ovary syndrome and the metabolic syndrome : a possible chronobiotic-cytoprotective adjuvant therapy
(Hindawi, 2018)
Abstract: Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that ...
The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome
(Taylor and Francis, 2015-11-06)
Impact of polycystic ovary syndrome, metabolic syndrome, obesity, and follicular growth arrest in women health
(Springer, 2021)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women in reproductive age. Depending on the diagnostic criteria used, the prevalence varies between 8% and 13% [1–4]. This syndrome was initially ...